When categories organise the conversation as much as the evidence
For many years I have written and spoken about sweeteners, particularly xylitol and erythritol. During that time, I noticed something curious. In both public discussion and professional debate, sweeteners are often treated as if they belong to a single category. Artificial sweeteners, sugar alcohols, and naturally derived alternatives are frequently discussed together, sometimes even interchangeably.
From a biochemical and physiological perspective, however, this grouping is difficult to justify. Artificial sweeteners, sugar alcohols, and naturally derived alternatives differ in molecular structure, metabolic pathways, and clinical implications. Yet once a category forms in public discussion, distinctions within it often become surprisingly difficult to sustain. Nuance gradually gives way to shorthand, and the debate begins to organise itself around the category rather than the individual substances.
This dynamic is familiar to anyone who has tried to introduce nuance into an established debate. Questions that once focused on individual compounds gradually become framed in broader terms. Substances with different metabolic properties become discussed together. Evidence relating to one group is sometimes interpreted as if it applies equally to another. Over time, the category itself becomes the central reference point.
Even within more specific classifications the same pattern can appear. Sugar polyols, for example – including xylitol, erythritol, sorbitol, maltitol, and isomalt – are frequently discussed as a single group, despite their differing effects within the oral environment and the gastrointestinal system.
Once a category forms, the debate often follows the category rather than the evidence.
In the case of sweeteners, the category has typically been constructed around the idea of “sugar substitutes”. The term appears straightforward, yet it quietly gathers together substances that behave quite differently in biological systems. Artificial sweeteners such as aspartame or sucralose, polyols such as xylitol and erythritol, and other emerging alternatives are often treated as members of a single family, even though their physiological effects vary considerably.
Yet those distinctions can matter considerably. Within the broad category of “sweeteners”, substances may behave very differently in biological systems. Sucralose, for example, has been shown in some experimental contexts to generate potentially harmful compounds when exposed to high temperatures, raising questions about its stability during cooking. Xylitol, by contrast, interacts with oral bacteria in a very different way. It is not fermented by Streptococcus mutans and has been shown to disrupt harmful oral biofilms, reducing the risk of dental caries without recognised harmful side effects when consumed in appropriate amounts.
The point here is not to reopen the sweetener debate. Rather, it illustrates how easily meaningful distinctions can disappear once discussions become organised around broad categories. When substances with very different biological properties are grouped together, the conversation may begin to revolve around the category itself rather than the individual mechanisms involved.
Categories, of course, serve an important purpose. They simplify complexity and make communication easier. Public health messages often rely on broad groupings in order to remain accessible. Scientific research also benefits from organising concepts into manageable frameworks. Yet categories also shape how evidence is interpreted. Once a particular grouping becomes established, new findings tend to be understood within its boundaries.
Over time the discussion may become increasingly detailed and sophisticated. More studies appear. Reviews are published. Guidance evolves. The conversation becomes more refined. Yet the underlying tension can remain remarkably stable. It is a process that I describe as refinement without relief.
Looking back, the sweetener debate therefore reveals something more general about the way health discussions develop. Scientific evidence does not enter an empty space. It arrives within conversations that are already structured by language, categories, and assumptions about how problems should be understood.
The lesson may therefore extend beyond sweeteners themselves. It invites us to look more carefully at the frameworks through which health behaviours, prevention, and risk are interpreted.
The same pattern appears in many other areas of health, where individual behaviour, environmental conditions, and institutional structures interact in complex ways.
Once those frameworks become visible, many familiar debates begin to look slightly different.